Investigating the Incidence of Contralateral Metachronous Testicular Cancer Following Radical Orchidectomy
Open Access
- 1 July 2025
- journal article
- Published by Brieflands in International Journal of Cancer Management
- Vol. 18 (1)
Abstract
Background: Testicular cancer is the most common malignancy in males aged 15 - 40 years. Although germ cell tumors (GCTs) account for the majority of cases, metachronous contralateral testicular cancer is rare. Objectives: This study aimed to evaluate the incidence of metachronous contralateral testicular cancer in patients without known risk factors, to assess the necessity of routine contralateral testicular biopsy. Methods: This historical cohort study included 220 patients under 40 years old with unilateral testicular GCT diagnosed before March 2019 at Shahid Modares Hospital, Tehran, Iran. Patients with cryptorchidism, family history of testicular cancer, testicular atrophy, or immunodeficiency were excluded. Finally, 95 patients completed at least a 5-year follow-up. Data were collected from medical records and patient interviews. Results: The mean age at diagnosis was 30.5 years. Seminoma was the most common pathology (50.5%). Right-sided tumors were more frequent (56.8%). After a minimum follow-up of 5 years, only one (1.05%) patient developed metachronous contralateral testicular cancer, occurring 5.5 years after the initial diagnosis. Conclusions: The incidence of metachronous contralateral testicular cancer in patients without risk factors was low (1.05%). Therefore, in strictly low-risk patients (no cryptorchidism, family history, or atrophy), routine contralateral testicular biopsy may not be necessary given the low incidence. Further studies with larger sample sizes are recommended to establish definitive guidelines.Keywords
This publication has 30 references indexed in Scilit:
- Contralateral Testicular Biopsy in Men with Testicular CancerEuropean Urology Focus, 2024
- European Association of Urology Guidelines on Testicular Cancer: 2023 UpdateEuropean Urology, 2023
- Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global AnalysisEuropean Urology Oncology, 2022
- Global patterns in testicular cancer incidence and mortality in 2020International Journal of Cancer, 2022
- Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancerUrologic Oncology: Seminars and Original Investigations, 2021
- Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular CancerEuropean Urology Focus, 2020
- Testicular CancerMedical Clinics of North America, 2018
- In utero exposure to female hormones and germ cell tumors in childrenCancer, 2006
- IS BIOPSY OF THE CONTRALATERAL TESTIS NECESSARY IN PATIENTS WITH GERM CELL TUMORS?Journal of Urology, 1997
- A Case of Bilateral Tumors of the TesticleJournal of Urology, 1932